Intravenous antibiotic durations for common bacterial infections in children: when is enough enough?

Area of Science:

• Pediatric Infectious Diseases
• Pharmacology
• Evidence-Based Medicine

Background:

• Intravenous antibiotic therapy durations in children often exceed clinical recovery.
• Current durations lack robust evidence and fail to account for individual patient factors.
• Prolonged therapy significantly impacts hospital length of stay and resource utilization.

Purpose of the Study:

• To review existing guidelines and evidence for intravenous antibiotic durations in pediatric bacterial infections.
• To propose a novel framework for optimizing antibiotic therapy duration.
• To guide clinical decision-making when current standards are inadequate or evidence-based.

Main Methods:

• Systematic review of guidelines and published literature on antibiotic durations for pediatric meningitis, bacteremia, UTI, and osteomyelitis.
• Analysis of evidence supporting current treatment durations.
• Development of a patient-centered framework incorporating clinical and individual factors.

Main Results:

• Evidence supporting fixed durations of intravenous antibiotics is often limited, especially post-clinical recovery.
• Common pediatric infections frequently receive prolonged antibiotic courses.
• A framework integrating patient-specific factors is proposed.

Conclusions:

• Current practices for intravenous antibiotic duration in children are not always evidence-based.
• A patient-centered framework can optimize therapy duration, considering infection severity, treatment response, and patient factors.
• Implementing this framework may lead to more appropriate antibiotic use and reduced healthcare costs.